Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer.

被引：42

作者：

Takei H. ^{[1
]}

Suemasu K. ^{[1
]}

Kurosumi M. ^{[1
]}

Horii Y. ^{[1
]}

Yoshida T. ^{[1
]}

Ninomiya J. ^{[1
]}

Yoshida M. ^{[1
]}

Hagiwara Y. ^{[1
]}

Kamimura M. ^{[1
]}

Hayashi Y. ^{[1
]}

Inoue K. ^{[1
]}

Tabei T. ^{[1
]}

机构：

[1] Division of Breast Surgery, Saitama Cancer Center, Saitama

来源：

Breast Cancer | 2007年 / 14卷 / 1期

关键词：

Sentinel lymph node biopsy; Axillary lymph node dissection; Regional nodal recurrence; Risk factor; Breast cancer;

D O I：

10.2325/jbcs.14.16

中图分类号：

学科分类号：

摘要：

BACKGROUND: A regional nodal recurrence is a major concern after a sentinel lymph node biopsy (SLNB) alone in patients with breast cancer. In this study we investigated patterns and risk factors of regional nodal recurrence after SLNB alone. PATIENTS AND METHODS: Between January 1999 and March 2005, a series of 1,704 consecutive breast cancer cases in 1,670 patients (34 bilateral breast cancer cases) with clinically negative nodes or suspicious nodes for metastasis who underwent SLNB at a single institute (Saitama Cancer Center) were studied. All 1,704 cases were classified based upon presence or absence of a metastatic lymph node, treated with or without axillary lymph node dissection (ALND). The site of first recurrence was classified as local, regional node, or distant. The regional node recurrences were subclassified as axillary, interpectoral, infraclavicular, supraclavicular, or parasternal. RESULTS: After a median follow-up period of 34 months (range, 2-83 months), first recurrence occurred in local sites in 32 (1.9%) cases, regional nodes in 26 (1.5%) cases, and distant sites in 61 (3.6%) cases. In 1,062 cases with negative nodes treated without ALND and 459 cases with positive nodes treated with ALND, 11 (1.0%) and 15 (3.3%) recurred in regional nodes, respectively, and 4 (0.4%) and 2 (0.6%) recurred in axillary nodes, respectively. Of 822 cases of invasive breast cancer with negative nodes treated with SLNB alone, 10 (1.4%) recurred in regional nodes, and 4 (0.5%) recurred in axillary nodes. In the 10 patients with regional nodal failure, all of the tumors were negative for estrogen receptor (ER) and/or progesterone receptor (PR) and were nuclear grade (NG) 3. CONCLUSIONS: The axillary recurrence rate was low in patients treated with SLNB alone. Omitting ALND is concluded to be safe after adequate SLNB. Risk factors for regional nodal failure after SLNB alone are negative hormone receptor status and high NG.

引用

页码：16 / 24

页数：8

共 337 条

[1]

Krag DN(1993)Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe Surg Oncol 2 335-340

[2]

Weaver DL(1994)Lymphatic mapping and sentinel lymphadenectomy for breast cancer Ann Surg 220 391-401

[3]

Alex JC(2003)A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer N Engl J Med 349 546-553

[4]

Fairbank JT(2006)Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial J Natl Cancer Inst 98 599-609

[5]

Giuliano AE(2005)Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials Lancet 365 1687-1717

[6]

Kirgan DM(2005)Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Lancet 366 2087-2106

[7]

Guenther JM(2003)Is it necessary to perform prospective randomized studies before sentinel node biopsy can replace routine axillary dissection Breast Cancer 10 179-187

[8]

Morton DL(2002)Sentinel lymph node biopsy without axillary dissection after an intraoperative negative histological investigation in 358 invasive breast cancer cases Breast Cancer 9 344-348

[9]

Veronesi U(2006)Tc-phytate is better than Surg Today 36 219-224

[10]

Paganelli G(2006)Tc-human serum albumin as a radioactive tracer for sentinel lymph node biopsy in breast cancer Breast Cancer 13 179-185

← 1 2 3 4 5 6 7 8 9 10 →